BiotechTube
Home/NeoImmuneTech/Luke Oh, Ph.D.
LO

Luke Oh, Ph.D.

Chief Operating Officer

NeoImmuneTech

Therapeutic Areas

OncologyInfectious Diseases

NeoImmuneTech Pipeline

DrugIndicationPhase
NT-I7 (efineptakin alfa)Solid Tumors (combo with anti-PD-1)Phase 1b/2

Leadership Team at NeoImmuneTech

SH
Se Hwan Yang, Ph.D.
Founder, President & CEO
NL
NgocDiep Le, M.D., Ph.D.
EVP & Chief Medical Officer
View full NeoImmuneTech profile